Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 19 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
ADRA2A
💬1. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Noradrenaline
Noradrenaline
💬1. ADRA2A
| Norepinephrine | 2件: 22 22, 296 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
ADRA2A
💬2. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Epinephrine
Epinephrine
💬2. ADRA2A
| Epinephrine | 3件: 46 46, 70, 96 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
ADRA2A
💬3. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Ephedrine
Ephedrine
💬3. ADRA2A
| Ephedrine | 1件: 11 11 💬3. ADRA2A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
ADRA2A
💬4. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Chlorpromazine
Chlorpromazine
💬4. ADRA2A
| Chlorpromazine | 1件: 254 254 💬4. ADRA2A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
ADRA2A
💬5. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Clonidine
Clonidine
💬5. ADRA2A
| Clonidine | 4件: 6 6, 65, 70, 78 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
ADRA2A
💬6. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Clozapine
Clozapine
💬6. ADRA2A
| Clozapine | 1件: 6 6 💬6. ADRA2A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 |
ADRA2A
💬7. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬7. ADRA2A
| Dexmedetomidine | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬7. ADRA2A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 |
ADRA2A
💬8. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Pimozide
Pimozide
💬8. ADRA2A
| Pimozide | 1件: 2 2 💬8. ADRA2A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 |
ADRA2A
💬9. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Droxidopa
Droxidopa
💬9. ADRA2A
| Droxidopa | 5件: 5 5, 6, 17, 169, 170 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 |
ADRA2A
💬10. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dipivefrin
Dipivefrin
💬10. ADRA2A
| Dipivefrin | 1件: 6 6 💬10. ADRA2A
|